常温机械灌注与静态冷保存在意向性循环死亡供肾移植中的随机对照试验
该随机对照试验将338例循环死亡供肾随机分配至静态冷保存组(n=168)或静态冷保存后加1小时常温机械灌注组(n=170),最终277例纳入意向性治疗分析。主要终点为移植后7天内需透析的延迟移植物功能,常温机械灌注组为82/135(60.7%),静态冷保存组为83/142(58.5%),校正比值比1.13(95%置信区间0.69-1.84),P=0.624。常温机械灌注未增加移植血栓、感染并发症或其他不良事件,但1小时灌注未降低延迟移植物功能发生率。
要点
- 常温机械灌注组延迟移植物功能发生率为60.7%(82/135),静态冷保存组为58.5%(83/142)。
- 校正比值比1.13(95%置信区间0.69-1.84),P=0.624,两组无显著差异。
- 常温机械灌注未增加移植血栓、感染并发症或其他不良事件,可行性、安全性良好。
核心结论
- 在静态冷保存结束后进行1小时常温机械灌注未能降低循环死亡供肾的延迟移植物功能发生率。
- 常温机械灌注被证明可行、安全且适合临床应用。
研究设计与样本
- 随机对照试验,共338例循环死亡供肾随机分配至静态冷保存组(n=168)或常温机械灌注组(n=170),最终277例纳入意向性治疗分析。
- 主要终点为移植后7天内需透析的延迟移植物功能。
主要发现
- 延迟移植物功能发生率:常温机械灌注组82/135(60.7%)vs 静态冷保存组83/142(58.5%)。
- 校正比值比1.13(95%置信区间0.69-1.84),P=0.624。
- 常温机械灌注未增加移植血栓、感染并发症或其他不良事件。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Kidney transplantation is the optimal treatment for end-stage renal disease, but it is still severely limited by a lack of suitable organ donors. Kidneys from donation after circulatory death (DCD) donors have been used to increase transplant rates, but these organs are susceptible to cold ischemic injury in the storage period before transplantation, the clinical consequence of which is high rates of delayed graft function (DGF). Normothermic machine perfusion (NMP) is an emerging technique that circulates a warmed, oxygenated red-cell-based perfusate through the kidney to maintain near-physiological conditions. We conducted a randomized controlled trial to compare the outcome of DCD kidney transplants after conventional static cold storage (SCS) alone or SCS plus 1-h NMP. A total of 338 kidneys were randomly allocated to SCS (n = 168) or NMP (n = 170), and 277 kidneys were included in the final intention-to-treat analysis. The primary endpoint was DGF, defined as the requirement for dialysis in the first 7 d after transplant. The rate of DGF was 82 of 135 (60.7%) in NMP kidneys versus 83 of 142 (58.5%) in SCS kidneys (adjusted odds ratio (95% confidence interval) 1.13 (0.69-1.84); P = 0.624). NMP was not associated with any increase in transplant thrombosis, infectious complications or any other adverse events. A 1-h period of NMP at the end of SCS did not reduce the rate of DGF in DCD kidneys. NMP was demonstrated to be feasible, safe and suitable for clinical application. Trial registration number: ISRCTN15821205 .
引用
- Hosgood SA, Callaghan CJ, Wilson CH, et al. Normothermic machine perfusion versus static cold storage in donation after circulatory death kidney transplantation: a randomized controlled trial. Nat Med. 2023. PMID: 37231075. doi:10.1038/s41591-023-02376-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。